Stock PGEN PRECIGEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Precigen, Inc.

Equities

PGEN

US74017N1054

Real-time Estimate Cboe BZX
Other stock markets
 12:07:13 2024-05-06 pm EDT 		5-day change 1st Jan Change
1.435 USD +1.06% Intraday chart for Precigen, Inc. +1.79% +6.34%
Apr. 24 Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy CI
Mar. 25 North American Morning Briefing : Tech in Focus on -2- DJ

Evolution of the average Target Price on Precigen, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c4cf22b658a.qvEMZVrzv5WwRFlzUstvnPuBptNfkavCLKh85xSEgsU.xMBLEz-ciNuHDTIxA7EY2ZjbwLkawvOFddlOoELs0J_aozkkKYn8pd8QaQ~812efcebb1b470ff111fe1360bc54667

Analyst Recommendations on Precigen, Inc.

Precigen Shares Fall After Downgrade From JPMorgan MT
JPMorgan Downgrades Precigen to Underweight From Neutral MT
JPMorgan Initiates Precigen at Neutral Rating MT
Cantor Fitzgerald Adjusts Price Target on Precigen to $10 From $7, Maintains Overweight Rating MT
Cantor Fitzgerald Starts Precigen at Overweight With $7 Price Target MT
HC Wainwright Adjusts Precigen's Price Target to $6 from $10, Keeps Buy Rating MT
PRECIGEN : B. Riley Raises Precigen's Price Target to $14 from $10, Keeps Buy Rating MT
PRECIGEN : Stifel Initiates Coverage on Precigen With Buy Rating, Sets Price Target at $13 MT
PRECIGEN : Wells Fargo Starts Precigen at Overweight With $14 Price Target MT
PRECIGEN : B. Riley Starts Precigen at Buy with $10 Price Target MT
PRECIGEN : HC Wainwright Adjusts Precigen's Price Target to $10 From $8, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
1.42 USD
Average target price
9 USD
Spread / Average Target
+533.80%
High Price Target
14 USD
Spread / Highest target
+885.92%
Low Price Target
6 USD
Spread / Lowest Target
+322.54%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Precigen, Inc.

JPMorgan Chase
Cantor Fitzgerald
HC Wainwright
Stifel Nicolaus
B. Riley

Ratings for Precigen, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PGEN Stock
  4. Consensus Precigen, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW